Literature DB >> 15226681

[COART France 2003 report on new socioeconomic data on osteoarthritis in France].

Marie Solignac.   

Abstract

RISING COSTS: According to the first evaluation of the socioeconomic impact of osteoarthritis in France conducted in 1993, the estimated annual cost was slightly less than one billion euros. In 2003, the annual cost was approximately 1.8 billion euros. Overall costs for osteoarthritis have thus increased by more than 80%, i.e. 8% per year. COST OF OFFICE VISITS: In 2002, 13.4 million office visits for osteoarthritis yielded an overall cost of 270 million euros and led to 17 million drug prescriptions (1.5 per consultation) yielding an overall cost of 574 million euros. HOSPITAL COSTS: With 127,000 acute-care admissions, 175,000 hospital days for day care and/or rehabilitation, and implantation of 118,000 hip or knee prostheses, the overall hospital cost came to 820 million euros in 2002. INDIRECT COSTS: Five million days of sick leave in 2002, in 88% of the cases for peripheral osteoarthritis, led to 180 million euros in indemnities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226681

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  8 in total

1.  Comparison of intra-articular injections of hyaluronic acid and corticosteroid in the treatment of osteoarthritis of the hip in comparison with intra-articular injections of bupivacaine. Design of a prospective, randomized, controlled study with blinding of the patients and outcome assessors.

Authors:  Sascha Colen; Michel P J van den Bekerom; Johan Bellemans; Michiel Mulier
Journal:  BMC Musculoskelet Disord       Date:  2010-11-16       Impact factor: 2.362

2.  The impact of concomitant depression on quality of life and health service utilisation in patients with osteoarthritis.

Authors:  Thomas Rosemann; Jochen Gensichen; Nina Sauer; Gunter Laux; Joachim Szecsenyi
Journal:  Rheumatol Int       Date:  2007-01-23       Impact factor: 3.580

3.  Problems and needs for improving primary care of osteoarthritis patients: the views of patients, general practitioners and practice nurses.

Authors:  Thomas Rosemann; Michel Wensing; Katharina Joest; Matthias Backenstrass; Cornelia Mahler; Joachim Szecsenyi
Journal:  BMC Musculoskelet Disord       Date:  2006-06-02       Impact factor: 2.362

4.  Expression Pattern of iNOS, BCL-2 and MMP-9 in the Hip Synovium Tissue of Patients with Osteoarthritis.

Authors:  Davor Caric; Sandra Zekic Tomas; Natalija Filipovic; Violeta Soljic; Benjamin Benzon; Sandro Glumac; Ivan Rakovac; Katarina Vukojevic
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

5.  A comparison of Kneipp hydrotherapy with conventional physiotherapy in the treatment of osteoarthritis of the hip or knee: protocol of a prospective randomised controlled clinical trial.

Authors:  Martin Schencking; Adriane Otto; Tobias Deutsch; Hagen Sandholzer
Journal:  BMC Musculoskelet Disord       Date:  2009-08-19       Impact factor: 2.362

6.  Prosthesis size distribution in Oxford phase III unicompartmental knee arthroplasty - Based on more than 1900 Chinese patients.

Authors:  Fang-Xing Wang; Hua-Ming Xue; Tong Ma; Tao Yang; Tao Wen; Yi-Hui Tu
Journal:  J Orthop       Date:  2021-05-16

Review 7.  Osteoarthritis pathogenesis - a complex process that involves the entire joint.

Authors:  G S Man; G Mologhianu
Journal:  J Med Life       Date:  2014-03-25

8.  Efficacy of intra-articular hyaluronic acid injections in hip osteoarthritis: a meta-analysis of randomized controlled trials.

Authors:  Bei Wu; Yao-Min Li; Yan-Cheng Liu
Journal:  Oncotarget       Date:  2017-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.